Radiation-absorbed dose from 201Tl-thallous chloride.

Area of Science:

• Nuclear medicine
• Radiation dosimetry
• Radiopharmaceutical safety

Background:

• Accurate radiation dosimetry is crucial for radiopharmaceutical safety.
• Previous estimates for 201Tl-thallous chloride did not fully account for testicular uptake.
• Updated biodistribution data are needed for precise dose calculations.

Purpose of the Study:

• To develop revised radiation dosimetry estimates for 201Tl-thallous chloride.
• To specifically address testicular uptake and reevaluate biodistribution in other organs.
• To compare new dose estimates with previously published values.

Main Methods:

• Quantitative testicular scintigraphy in 28 patients.
• Reanalysis of published biodistribution data.
• Radiation dose calculation using the MIRD schema, including age-dependent testicular dose.
• Inclusion of dose contributions from potential radiocontaminants (200Tl, 202Tl, 203Pb).

Main Results:

• Adult testicular radiation dose is approximately half of previous estimates (0.21 mGy/MBq).
• Pediatric testicular dose increases significantly with decreasing age, reaching 7.5 mGy/MBq for newborns.
• Effective dose is approximately 0.16 mSv/MBq.
• Radiocontaminants can contribute up to 20% of the total dose, especially 202Tl after 5-day shelf life.

Conclusions:

• Recommended use of revised dose values for adult testicular radiation dose estimation from 201Tl-thallous chloride.
• Caution advised for pediatric procedures due to significantly higher testicular radiation doses in younger patients.
• Consideration of radiocontaminant contributions is essential for accurate dose estimation.